Physician
Kids Kare Pediatrics PC
Kids Kare Pediatrics PC was paid $4.73M by Medicaid between Jan 2018 and Apr 2021, across 93 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 54% of everything it billed.
33Billing provider infoKIDS KARE PEDIATRICS PC
PHOENIX, AZ 85013
PHOENIX, AZ 85013
33aNPI1508829326assigned 04/11/2006
33bProvider typeFamily Medicine Physician
28Total paid$4.73M
24GClaims124,393
24DCodes billed93
24AFirst – last monthJan 2018 – Apr 2021
Compared with peers
Next to other Family Medicine Physician providers in Arizona
Rank by total paid#25 of 442
Median peer was paid$77K
This provider vs. median61×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 41,808 | $1.69M | |
| 2019 | 36,698 | $1.44M | |
| 2020 | 41,073 | $1.37M | |
| 2021 | 4,814 | $239K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 54% | 35,980 | 29,746 | $2.55M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 16,033 | 14,278 | $769K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.6% | 4,400 | 4,341 | $311K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.9% | 2,981 | 2,860 | $233K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.3% | 2,826 | 2,787 | $201K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.2% | 7,414 | 7,199 | $198K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.4% | 2,415 | 2,349 | $162K |
| 92567 | 1.5% | 11,089 | 9,968 | $70K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 408 | 380 | $25K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 121 | 12 | $24K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 316 | 294 | $23K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,682 | 1,651 | $23K |
81 more codes
| 99401 | <1% | 977 | $22K | |
| 54450 | <1% | 275 | $16K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 812 | $15K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 445 | $11K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 100 | $9K |
| 81002 | <1% | 2,851 | $8K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 821 | $8K |
| 99173 | <1% | 11,510 | $7K | |
| 99385 | <1% | 81 | $7K | |
| 99381 | <1% | 89 | $7K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 313 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 356 | $5K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,657 | $4K |
| 99188 | <1% | 291 | $4K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 34 | $3K |
| 99382 | <1% | 30 | $2K | |
| 99383 | <1% | 27 | $2K | |
| 69210 | <1% | 50 | $1K | |
| 90686 | <1% | 3,026 | $1K | |
| 99384 | <1% | 12 | $1K | |
| 96160 | <1% | 323 | $994.52 | |
| 99000 | <1% | 1,404 | $756.37 | |
| 99460 | <1% | 14 | $736.35 | |
| 96127 | <1% | 583 | $672.25 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 21 | $633.91 |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 14 | $624.93 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 420 | $603.02 |
| 90651 | <1% | 1,112 | $561.88 | |
| 90670 | <1% | 1,970 | $450.87 | |
| 94664 | <1% | 30 | $416.91 | |
| 87632 | <1% | 22 | $239.51 | |
| A4617 | Mouth piece | <1% | 482 | $222.11 |
| 80061 | Lipid panel | <1% | 41 | $208.56 |
| 93000 | <1% | 12 | $189.23 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 21 | $187.76 |
| 90474 | <1% | 13 | $165.13 | |
| 90698 | <1% | 1,228 | $163.31 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 24 | $156.35 |
| 36416 | <1% | 289 | $142.23 | |
| 90744 | <1% | 648 | $130.99 | |
| 86580 | <1% | 15 | $95.72 | |
| 83655 | <1% | 15 | $95.22 | |
| 90715 | <1% | 272 | $61.81 | |
| 90696 | <1% | 117 | $46.95 | |
| 90710 | <1% | 198 | $46.95 | |
| 94760 | <1% | 1,088 | $46.82 | |
| 87486 | <1% | 22 | $39.38 | |
| 87541 | <1% | 22 | $39.38 | |
| 87581 | <1% | 22 | $39.38 | |
| 90658 | <1% | 136 | $36.48 | |
| 81025 | <1% | 24 | $36.40 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 16 | $32.70 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 263 | $28.31 |
| 90756 | <1% | 123 | $18.91 | |
| 90633 | <1% | 651 | $15.58 | |
| 90680 | <1% | 760 | $13.91 | |
| A4616 | Tubing (oxygen), per foot | <1% | 451 | $7.41 |
| 81001 | <1% | 20 | $3.54 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 231 | $3.01 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 14 | $1.40 |
| 3008F | 0% | 204 | $0.00 | |
| 90716 | 0% | 94 | $0.00 | |
| 90620 | 0% | 49 | $0.00 | |
| 87640 | 0% | 21 | $0.00 | |
| 87498 | 0% | 21 | $0.00 | |
| 90656 | 0% | 66 | $0.00 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 0% | 36 | $0.00 |
| 90647 | 0% | 13 | $0.00 | |
| 3074F | 0% | 40 | $0.00 | |
| 3051F | 0% | 14 | $0.00 | |
| 90734 | 0% | 766 | $0.00 | |
| 1160F | 0% | 94 | $0.00 | |
| 90685 | 0% | 183 | $0.00 | |
| 90621 | 0% | 12 | $0.00 | |
| 90707 | 0% | 78 | $0.00 | |
| 90700 | 0% | 41 | $0.00 | |
| 87641 | 0% | 21 | $0.00 | |
| 87799 | 0% | 21 | $0.00 | |
| 87634 | 0% | 21 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 21 | $0.00 |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLOPEZ, LUZ (VICEPRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Ohana Kids & Family Kare LLC | Mesa, AZ | $4.75M |
| DR Grabowski PC | Bellevue, WA | $122K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.